Pediatric stroke is considered an infrequent complication of COVID-19. Focal cerebral arteriopathy (FCA) is one of the most common causes of arterial ischemic stroke in a previously healthy child. The present report describes a toddler with FCA most likely induced by SARS-CoV-2 infection who showed significant clinical improvement that may be related to injection of intra-arterial nimodipine. To our knowledge, this is the first reported use of nimodipine in this setting.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339169 | PMC |
| http://dx.doi.org/10.1016/j.ejpn.2022.07.007 | DOI Listing |
Publication Analysis
Top Keywords
clinical improvement
8
covid-19 focal
8
focal cerebral
8
cerebral arteriopathy
8
intra-arterial nimodipine
8
improvement toddler
4
toddler covid-19
4
arteriopathy intra-arterial
4
nimodipine pediatric
4
pediatric stroke
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!